Corvid Pharmaceuticals Private Limited, a active private limited company, was established on 28 August 2012 in Navi Mumbai, Maharashtra, India. Engaging in api manufacturers within the professional, scientific and technical sector, it holds CIN: U33100MH2012PTC235053. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rajesh Chandrakumar Hedaoo (Director), Swati Rajesh Hedaoo (Director), Vijay Ramchandra Kolhekar (Director). Past directors included Kanchan Sanjay Kale, Sarika Ganesh Vyavahare, Supriya Sanjay Aher. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Plot No. 51, Road No.3, Sector1/S, New Panvel (E), Navi Mumbai, Maharashtra, 410206.
U33100MH2012PTC235053
235053
28 August 2012
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Corvid Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Chandrakumar Hedaoo | Director | 26 May 2016 | Current |
| Swati Rajesh Hedaoo | Director | 28 Aug 2012 | Current |
| Vijay Ramchandra Kolhekar | Director | 28 Aug 2012 | Current |
| Harendra Singh | Director | 28 Aug 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jul 2013 | Past |
| Pramod Abcsdd | Director | 26 May 2016 | Past |
| Pramod Abcsdd | Director | 17 Mar 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Corvid Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 96.58% increase. The company also saw a substantial improvement in profitability, with a 4842.44% increase in profit. The company's net worth Soared by an impressive increase of 63.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Corvid Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Corvid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Corvid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corvid Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Corvid Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
The activity Corvid Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was completed.
The activity Rajesh Chandrakumar Hedaoo was appointed as a Director was appointed as a Director on 26 May 2016 & has been associated with this company since 9 years 6 months . was completed.
Progress on Swati Rajesh Hedaoo was appointed as a Director was appointed as a Director on 28 Aug 2012 & has been associated with this company since 13 years 3 months . was documented.
Vijay Ramchandra Kolhekar was appointed as a Director was appointed as a Director on 28 Aug 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
Progress on Harendra Singh was appointed as a Director was appointed as a Director on 28 Aug 2012 & has been associated with this company since 13 years 3 months . was documented.
The CIN of Corvid Pharmaceuticals Private Limited is U33100MH2012PTC235053.
Corvid Pharmaceuticals Private Limited is headquartered at Plot No. 51, Road No.3, Sector1/S, New Panvel (E), Navi Mumbai, Maharashtra, 410206.
Corvid Pharmaceuticals Private Limited was incorporated on 28 August 2012.
The current directors of Corvid Pharmaceuticals Private Limited are
The primary industry of Corvid Pharmaceuticals Private Limited is Professional, Scientific And Technical.
Corvid Pharmaceuticals Private Limited is unlisted.
The authorized capital of Corvid Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Corvid Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX